Related Experiment Video
Updated: Oct 10, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
Toxic metronidazole-induced MRI changes
C K Horlen1, C F Seifert, C S Malouf
1School of Pharmacy, Texas Tech University Health Sciences Center, Lubbock 79430, USA.
Objective:
To report a case of changes documented by magnetic resonance imaging (MRI) of the head probably due to accumulation of metronidazole in a patient with liver dysfunction.
Case Summary:
A 34-year-old Hispanic man with cirrhosis and hepatitis C being treated with metronidazole for Bacteroides fragilis meningitis and bacteremia developed ataxia, disorientation, and peripheral neuropathy. An MRI at the time meningitis was diagnosed was negative. After the patient received > 60 g of metronidazole, an MRI revealed increased signal intensity below, behind, and lateral to the fourth ventricle. Concomitant metronidazole serum concentration was toxic at 35.1 micrograms/mL.
Discussion:
This is the second reported case of metronidazole-induced MRI changes. Metronidazole is known to accumulate in patients with liver dysfunction and can cause peripheral neuropathy and central nervous system (CNS) dysfunction; these effects may take up to two years to completely resolve.
Conclusions:
Metronidazole dosages should be reduced in patients with liver dysfunction to prevent the accumulation of metronidazole, which can lead to CNS dysfunction and peripheral neuropathy.
Insights
Metronidazole accumulation in patients with liver dysfunction can cause central nervous system (CNS) and peripheral neuropathy. This case highlights MRI changes associated with metronidazole toxicity, emphasizing dose reduction in liver impairment.
Area of Science:
- Neurology
- Pharmacology
- Radiology
Background:
- Metronidazole is a commonly prescribed antibiotic.
- Liver dysfunction can impair drug metabolism and increase the risk of toxicity.
- Neurological complications associated with metronidazole are well-documented.
Observation:
- A patient with cirrhosis and hepatitis C developed ataxia, disorientation, and peripheral neuropathy while on metronidazole therapy.
- Magnetic resonance imaging (MRI) revealed characteristic signal changes in the brainstem and cerebellum after significant metronidazole accumulation.
- Toxic serum metronidazole concentration was confirmed.
Findings:
- This case demonstrates metronidazole-induced neurotoxicity, evidenced by clinical symptoms and specific MRI findings.
- The observed MRI changes, including increased signal intensity in the cerebellar and brainstem regions, are consistent with metronidazole accumulation.
- The patient's liver dysfunction likely contributed to the elevated and toxic serum levels of metronidazole.
Implications:
- This case underscores the importance of cautious metronidazole dosing in patients with hepatic impairment to prevent neurotoxicity.
- Healthcare providers should be vigilant for neurological symptoms in patients with liver dysfunction receiving metronidazole.
- Awareness of these potential MRI changes can aid in the diagnosis and management of metronidazole-induced neurotoxicity.
Related Concept Videos
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Magnetic Resonance Imaging
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies IV: Magnetic Resonance Imaging
Drug Toxicity: Risk factors
